Primavera Venture Partners (PVP)

Primavera Venture Partners (PVP) is the venture capital arm of Primavera Capital Group, a premier China-based global investment firm with portfolio companies including Alibaba, Ant Group, ByteDance, Junlebao, Kuaishou, Laobaixing, Xpeng, Yum China, among others. PVP focuses on early-stage innovative tech companies in artificial intelligence, industrial Internet, and healthcare etc. *

	Start	2021-09-20 established (approx)
	Group	Primavera Capital (Group)
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Zou, Johnny (Primavera Capital 202109 at Primavera Venture Partners)

	City	n. a.
		Address record changed: 2022-11-21

Basic data	Employees	n. a.

		* Document for »About Section«: Accession Therapeutics Ltd.. (9/20/21). "Press Release: Bent Jakobsen Starts Novel Immune-oncology Firm Accession Therapeutics, Primavera Venture Partners and Birk Venture among First Investors". Oxford.

		Record changed: 2022-11-21

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for Primavera Capital (Group)

[1] Accession Therapeutics Ltd.. (9/20/21). "Press Release: Bent Jakobsen Starts Novel Immune-oncology Firm Accession Therapeutics, Primavera Venture Partners and Birk Venture among First Investors". Oxford....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)